Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy
Type 2 diabetes mellitus is a serious medical and social problem. The danger of the disease is associated with epidemic growth rates and chronic complications, leading to early disability, decreased quality of life and mortality. The prevention of diabetes complications is based on the optimal gluco...
Main Authors: | E. V. Biryukova, I. A. Morozova, S. V. Rodionova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2021-01-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5980 |
Similar Items
-
Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
by: Soon-Jib Yoo, et al.
Published: (2021-11-01) -
Efficacy and pathogenetic justification for the use of vildagliptin in patients with type 2 diabetes mellitus
by: V.I. Pankiv
Published: (2019-10-01) -
What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019
by: Marina V. Shestakova, et al.
Published: (2020-04-01) -
THE ROLE OF GLYCATED HEMOGLOBIN IN THE DIAGNOSIS AND IMPROVED PROGNOSIS OF DIABETES MELLITUS
by: E. V. Biryukova
Published: (2017-12-01) -
Priorities of self-monitoring of blood glucose in a treatment of diabetes mellitus
by: Elena V. Biryukova, et al.
Published: (2019-03-01)